Association of emotional state with treatment compliance and clinical symptom improvement in pediatric bronchopneumonia patients
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND Anxiety and depression adversely affect clinical outcomes in children with bronchopneumonia but are often overlooked. AIM To clarify the relationship between emotional state, treatment compliance, and symptom improvement in children with bronchopneumonia. METHODS A total of 306 children with bronchopneumonia (January 2022 to January 2025) were included. Clinical data on emotional state (the Depression Self-Rating Scale for Children and the Screen for Child Anxiety Related Emotional Disorders), treatment compliance, and symptom improvement (time to wheezing, fever, lung rales, and cough resolution) were collected. Anxiety/depression status across different clinical characteristics was assessed, and its correlation with treatment compliance and symptom improvement was analyzed. RESULTS Depression Self-Rating Scale for Children and Screen for Child Anxiety Related Emotional Disorders scores were significantly higher in children with a disease duration > 4 days and moderate illness but showed no significant correlation with gender or age. Anxious or depressed children showed markedly lower overall compliance, with longer symptom-resolution times. CONCLUSION In pediatric bronchopneumonia, adverse emotional states are closely associated with poorer treatment compliance and slower symptom improvement. Reducing anxiety or depression may enhance compliance and alleviate symptoms.
Fields of Study & Subjects
Pneumonia and Respiratory Infections
Child and Adolescent Psychosocial and Emotional Development
COVID-19 and Mental Health
Publication details
- Journal / source
- World Journal of Psychiatry
- Volume
- 16
- Issue
- 4
- Publication date
- 27 March 2026
- Language
- EN